University of Texas Southwestern Medical Center Division of NeuroCritical Care 75390-8550 — Dallas, Texas

University of Texas Southwestern Medical Center Division of NeuroCritical Care 75390-8550 is a clinical research site located in Dallas, Texas, United States 75390-8550.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Texas Southwestern Medical Center Division of NeuroCritical Care 75390-8550 has participated in 1 clinical trials.

Therapeutic areas: Portopulmonary Hypertension.

Sponsors: Actelion.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas Southwestern Medical Center Division of NeuroCritical Care 75390-8550?

University of Texas Southwestern Medical Center Division of NeuroCritical Care 75390-8550 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas Southwestern Medical Center Division of NeuroCritical Care 75390-8550 conducted?

University of Texas Southwestern Medical Center Division of NeuroCritical Care 75390-8550 has 1 clinical trials on record. Their work covers Portopulmonary Hypertension.

Is University of Texas Southwestern Medical Center Division of NeuroCritical Care 75390-8550 accredited by Crixeo Health?

University of Texas Southwestern Medical Center Division of NeuroCritical Care 75390-8550 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas Southwestern Medical Center Division of NeuroCritical Care 75390-8550?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.